Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
CJC-1295 (no DAC) is a growth hormone releasing hormone (GHRH) analog that extends each GH pulse
1 The main consideration is digestive comfort
Patients should understand that this medication supports auditory cell signaling rather than stopping vertigo attacks
Oral peptides: Most peptides marketed as oral supplements (gummies, capsules) have poor bioavailability because the digestive tract breaks them down
This treatment may not be appropriate for patients who are pregnant, breastfeeding, have a personal or family history of medullary thyroid cancer, MEN2, active eating disorders, history of pancreatitis, severe gastrointestinal disease, or certain other medical conditions